跳转至内容
Merck
CN

主要文件

查看所有文档

919624

TissueFab® bioink 

(GelHA)ma -Vis/405 nm

别名:

Bioink, HAMA, Hyaluronic Acid methacryloyl, Hyaluronic acid, Hyaluronic acid methacrylamide, Hyaluronic acid methacrylate, Sodium hyaluronate

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.23
UNSPSC Code:
12352201
Sterility:
sterile-filtered
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

100

description

suitable for 3D bioprinting applications

sterility

sterile-filtered

form

viscous liquid (gel)

impurities

<5 CFU/g Bioburden (Fungal), <5 CFU/g Bioburden (Total Aerobic)

color

colorless to pale yellow

particle size

0.2 μm

pH

6.5-7.5

application(s)

3D bioprinting

Application

TissueFab® - HAMA-Vis bioink is a hyaluronic acid methacrylate and GelMA based bioink for 3D bioprinting applications. The formulation is optimized for 3D bioprinting of tissues and constructs using extrusion based 3D bioprinters, and can be can be used to bioprint cell-laden hydrogels in desired shape without any supporting material. The crosslinking of printed structures can be done in one step using visible light for further culture and maturation of cells for tissue engineering and regenerative medicine applications.

Packaging

10 mL in glass bottle

Legal Information

TISSUEFAB is a registered trademark of Merck KGaA, Darmstadt, Germany

Still not finding the right product?

Explore all of our products under

存储类别

10 - Combustible liquids

wgk

WGK 3

法规信息

低风险生物材料

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

3D生物打印生物墨水选择指南

生物墨水可3D生物打印形成功能组织结构，从而应用于药物筛选、疾病建模和体外移植。针对特定组织工程应用选择生物墨水和打印方法。

Bioink Selection for 3D Bioprinting

Bioinks enable 3D bioprinting of tissue constructs for drug screening and transplantation; select suitable bioinks for specific tissue engineering.

Recent Advances in 3D-Bioprinting-based Drug Screening

Learn how 3D bioprinting is revolutionizing drug discovery with highly-controllable cell co-culture, printable biomaterials, and its potential to simulate tissues and organs. This review paper also compares 3D bioprinting to other advanced biomimetic techniques such as organoids and organ chips.

Michelle T Poldervaart et al.
PloS one, 12(6), e0177628-e0177628 (2017-06-07)
In bone regenerative medicine there is a need for suitable bone substitutes. Hydrogels have excellent biocompatible and biodegradable characteristics, but their visco-elastic properties limit their applicability, especially with respect to 3D bioprinting. In this study, we modified the naturally occurring

全球贸易项目编号

货号GTIN
919624-1EA04065265585187